- Category: Research
Research
Low vision rehab less effective in patients with hearing loss
Patients with hearing impairment less likely to achieve clinically meaningful improvement from vision rehabilitation.
Research
Neuvasq highlights novel antibody approach for restoring blood-retina barrier in wet AMD and DME
Preclinical data of NVQ401 and NVQ501 demonstrate improvements in BRB integrity and function in vascular retinopathy models.
Research
Metformin may slow postoperative PCO
Study findings suggest the common diabetes drug may reach the lens capsule and reduce cell activity linked to secondary cataract formation.
Research
PreserVision AREDS3 launch highlights B vitamins’ potential role in AMD
Bausch + Lomb advanced PreserVision formula spotlights the unique B-vitamin complex in reducing the risk for AMD, especially in earlier stages.
Research
Dexamethasone drops may preserve vision in ROP
Low-dose topical dexamethasone at the type 2 ROP stage reduced the need for laser or anti-VEGF treatment by more than 80%.
Research
New IZERVAY findings link GA treatment to improved likelihood of retaining driving eligibility
Post hoc analysis demonstrates IZERVAY reduces risk of progressing to losing driving eligibility in GA patients.
Research
White paper supports Sequel progressive addition lenses for digital eye strain
After 6 weeks, patients experienced an average of 71% reduction in DES symptoms and three-fourths reported no end-of-day fatigue.
Research
Oculis's global DME consensus study identifies critical gaps in care
Expert panel highlights disease management while emphasizing the importance of early intervention and non-invasive treatment options based on BCVA outcomes.
Research
Do anti-VEGF injections increase cataract risk?
A 15-year retrospective study found injected eyes nearly six times more likely to undergo cataract surgery than their untreated fellow eyes.
Research
Real-world TED data finds disease advances beyond acute phase
Real-world study demonstrates heterogeneous disease progression in TED, challenging the traditional self-limited paradigm.
Research
Breakthrough trial finds MiYOSMART iQ spectacle lenses halt childhood myopia progression
Latest 12-month data details highest myopia-control efficacy results reported to date in myopes as young as age 4 wearing HOYA’s D.I.M.S. technology.
Research
Are blue-light blocking IOLs actually effective?
Yellow-tinted lenses were associated with a decline in macular pigment density over 3 years, the opposite of the intended effect.
Research
Epioxa phase 3 pivotal trial supports early intervention for keratoconus management
New findings reinforce epi-on CXL's role in early keratoconus treatment, Glaukos is planning an extension trial for long-term monitoring.
Research
Researchers question safety of red light among pediatric myopes
Laboratory analysis suggests some devices may exceed established retinal safety limits during recommended treatment times.
Research
Could human breast milk treat dry eye disease?
Narrative review traces ophthalmic uses of human milk back to anciant Egyptian papyrus, finding the biology behind it might hold up.
Research
Study: Pickleball-related eye injuries on the rise
National review finds rising emergency visits, frequent ball-strike trauma, and a clear case for protective eyewear.
Research
Popular GLP-1RA may increase risk for ION and vision loss
Study findings suggest a potential dose- and formulation-dependent association between semaglutide and ischemic optic neuropathy
Research
Maternal diabetes exposure increases severe ROP risk
In-utero exposure to maternal diabetes may raise the odds, even in infants who appear lower risk by traditional measures.
Research
Does smoking age your eyes?
Mouse model study finds cigarette smoke may cause changes in eye cells similar to aging damage, with younger and older cells differing in protection.
Research